VRTX icon

Vertex Pharmaceuticals
VRTX

Overview Fund Activity

1,431 hedge funds and large institutions have $96.8B invested in Vertex Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 241 funds opening new positions, 556 increasing their positions, 478 reducing their positions, and 60 closing their positions.

Holders
1,431
Holders Change
+160
Holders Change %
+12.59%
% of All Funds
20.99%
Holding in Top 10
41
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+32.26%
% of All Funds
0.6%
New
241
Increased
556
Reduced
478
Closed
60
Calls
$895M
Puts
$974M
Net Calls
-$79.1M
Net Calls Change
-$120M

Top Buyers

1
Capital World Investors
1
Capital World Investors
California
$8.87B
2
Morgan Stanley
2
Morgan Stanley
New York
$2.43B
3
Amundi
3
Amundi
France
$1.14B
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$952M
5
Aberdeen Group
5
Aberdeen Group
United Kingdom
$236M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$5.28B
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$2.13B
3
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$2.4B
4
BlackRock
4
BlackRock
New York
$8.9B
5
AllianceBernstein
5
AllianceBernstein
Tennessee
$2.86B
Name Market Value Shares Shares
Change 		Shares
Change %
Vanguard Group
1
Vanguard Group
Pennsylvania
$9.07B 22,282,180 +298,824 +1%
BlackRock
2
BlackRock
New York
$8.9B 21,881,203 -704,023 -3%
Capital World Investors
3
Capital World Investors
California
$8.87B 21,805,770 +3,824,103 +21%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$5.28B 12,979,511 -1,380,926 -10%
State Street
5
State Street
Massachusetts
$4.92B 12,083,818 +44,272 +0.4%
AllianceBernstein
6
AllianceBernstein
Tennessee
$2.86B 7,039,738 -486,718 -6%
Morgan Stanley
7
Morgan Stanley
New York
$2.43B 5,960,910 +3,090,809 +108%
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$2.4B 5,887,412 -962,654 -14%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$2.3B 5,673,419 +77,445 +1%
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$2.29B 5,624,265 -481,587 -8%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$2.13B 5,228,538 -1,297,313 -20%
Jennison Associates
12
Jennison Associates
New York
$1.61B 3,944,913 +147,248 +4%
Massachusetts Financial Services
13
Massachusetts Financial Services
Massachusetts
$1.48B 3,625,802 -265,992 -7%
Capital Research Global Investors
14
Capital Research Global Investors
California
$1.45B 3,567,664 +195,080 +6%
Loomis, Sayles & Company
15
Loomis, Sayles & Company
Massachusetts
$1.28B 3,134,852 -28,616 -0.9%
Norges Bank
16
Norges Bank
Norway
$1.24B 3,042,288 +368,382 +14%
Amundi
17
Amundi
France
$1.14B 2,718,117 +774,696 +40%
Northern Trust
18
Northern Trust
Illinois
$1.09B 2,680,597 -132,966 -5%
UBS AM
19
UBS AM
Illinois
$1.06B 2,599,904 -173,895 -6%
ClearBridge Investments
20
ClearBridge Investments
New York
$1.05B 2,592,575 -350,609 -12%
Ameriprise
21
Ameriprise
Minnesota
$1.02B 2,510,029 -427,783 -15%
Bank of America
22
Bank of America
North Carolina
$991M 2,435,920 +82,919 +4%
Janus Henderson Group
23
Janus Henderson Group
United Kingdom
$952M 2,339,979 +681,156 +41%
Invesco
24
Invesco
Georgia
$912M 2,242,107 +225,327 +11%
Legal & General Group
25
Legal & General Group
United Kingdom
$839M 2,061,605 +21,247 +1%
1
2 3 4 5